Dopamine receptors: Novel insights from biochemical and genetic studies

Neuroscientist

Volumn 6, Issue 2, 2000, Pages 127-138

  Schmauss, Claudia ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Dopamine receptors; Gene targeting; Homologous recombination; Oligomeric assembly

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR;

DOPAMINE RELEASE; DRUG POTENCY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW;

EID: 0034000344     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385840000600210     Document Type: Review

References (48)

1. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopa mine receptors: from structure to function. Physiol Rev 1998;78:189-225.
2. Levant B. The D3 dopamine receptor: neurobiology and poten tial clinical relevance. Pharmacol Rev 1997;49:231-52.
3. Shafer RA, Levant B. The D3 dopamine receptor in cellular and organismal function. Psychopharmacology 1998;135:1-16.
4. Sibley DR. New insight into dopaminergic receptor function us ing antisense and genetically altered animals. Ann Rev Pharmacol Toxicol 1999;39:313-41.
5. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol 1990;213:899-929.
6. Unger VM, Hargrave PA, Baldwin LM, Schertler GF. Arrangement of rhodopsin transmembrane alpha-helices. Nature 1997;389:203-6.
7. O'Dowd BF. Structure of dopamine receptors. J Neurochem 1993;60:804-16.
8. O'Dowd BF, Hnatowich M, Caron MG, Lefkowitz RJ, Bovier RJ. Palmytoylation of the human β2 adrenergic receptor: mutation of CYS341 in the carboxy tail leads to an uncoupled, non-palmitoylated form of the receptor. J Biol Chem 1989;264:7564-9.
9. Ovchinnikov V, Abdulaev N, Bogachuk A. Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitoylated. FEBS Lett 1988;230:1-5.
10. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 1988;240:1310-16.
11. Maggio R, Vogel Z, Wess J. Coexpression studies with mutant muscarinic / adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-coupled receptors. Proc Natl Acad Sci U S A 1993;90:3103-7.
12. Wreggett KA, Wells W. Cooperativity manifest in the binding properties of purified cardia muscarinic receptors. J Biol Chem 1995;270:22488-99.
13. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996;271:16384-92.
14. Ng GYK, Mouillac B, George SR, Caron M, Dennis M, Bovier M, et al. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol 1994;267:7-19.
15. Ng GYK, O'Dowd BF, Caron M, Dennis M, Brann MR, George SR. Phosphorylation and palmitoylation of the human D21 dopa mine receptor in Sf9 cells. J Neurochem 1994;63:1589-95.
16. Zawarynski P, Tallerico T, Seeman P, Lee SP, O'Dowd BF, George SR. Dopamine D2 receptor dimers in human and rat brain. FEBS Lett 1998;441:383-6.
17. Nimchinsky EA, Hof PR, Janssen WGM, Morrison JH, Schmauss C. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem 1997;272:29229-37.
18. Schmauss C. Enhanced cleavage of an atypical intron of dopa mine D3-receptor pre-mRNA in chronic schizophrenia. J Neurosci 1996;16:7902-9.
19. 3nf-like immunoreactivity in human brain. J Biol Chem 1994;269:29220-6.
20. Wang Z-Z, Hardy SF, Hall ZW. Assembly of the nicotinic acetylcholine receptor. J Biol Chem 1996;271:27575-84.
21. Jung M-Y, Skryabin BV, Arai M, Abbondanzo S, Fu D, Brosius J, et al. Potentiation of the D2-mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. Neuroscience 1999;91:911-24.
22. George SR, Lee SP, Varghese G, Zeman PR, Seeman P, Ng GYK, et al. A transmembrane domain-derived peptide inhibits Dl dopamine receptor function without affecting receptor oligomerization. J Biol Chem 1998;273:30244-8.
23. Accili D, Fishbum CS, Drago J, Steiner H, Lachowicz JE, Park B-H, et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci U S A 1996;93:1945-9.
24. Weiss S. Fluorescence spectroscopy of single biomolecules. Science 1999;283:1676-83.
25. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994;79:729-42.
26. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, et al. Altered striatal function in a mutant mouse lacking DIA dopamine receptors. Proc Natl Acad Sci U S A 1994;91:12564-8.
27. Moratalla R, Xu M, Tonegawa S, Graybiel AM. Cellular responses to psychostimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci U S A 1996;93:14928-33.
28. Xu M, Hu X-T, Cooper DC, Moratalla R, Graybiel AM, White FJ, et al. Elimination of cocaine-induced hyperactivity and dopa mine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 1994;79:945-55.
29. IA dopamine receptors. Neuroscience 1998;86:135-46.
30. Miner L, Drago J, Chamberlain PM, Donovan D, Uhl GR. Retained cocaine conditioned place preference in D1 receptor deft cient mice. Neuroreport 1995;6:2314-16.
31. 1A-deficient mutant mice. Eur J Neurosci 1998;10:2426-32.
32. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, et al. Behavioral phenotypes of inbred strains: implications and recommendations for molecular studies. Neuropharmacology 1997;132:107-24.
33. Drago J, Gerfen CR, Westphal H, Steiner H. D1-dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 1996;74:813-23.
34. Baik J-H, Picetti R, Dalardi A, Thirlet G, Dierich A, Depaulis A, et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 1995;377:424-8.
35. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 1997;19:103-13.
36. Jung M-Y, Hof PR, Schmauss C. Expression of calbindin-D28K immunoreactivity in the dorsal striatum of mice lacking dopa mine D2, D3, and D2/D3 receptors. Soc Neurosci Abstr 1999;25:151-8.
37. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang, et al. Locomotor activity in D2 dopa mine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 1998;18:3470-9.
38. Schöneberg T, Liu J, Wess J. Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled re ceptors. J Biol Chem 1995;270:18000-6.
39. 2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 1997;19:115-26.
40. Mercuri NB, Saiardi A, Bonci A, Picetti R, Calabresi P, Bernadi G, et al. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 1997;79:323-7.
41. L'hirondel ML, Cheramy A, Godeheu G, Artaud F, Saiardi A, Borreli E, et al. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res 1998;792:253-62.
42. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borreli E. Absence of opiate rewarding effects in mice lacking dopamine D2 and D3 receptors. Nature 1997;388:586-9.
43. Phillips T, Brown KJ, Burkhart-Kasch S, Wenger CD, Kelly MA, Rubinstein M, et al. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nature Neurosci 1998;I:610-15.
44. El-Ghundi M, George SR, Drago J, Fletcher PJ, Fan T, Nguyen T, et al. Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior. Eur J Pharmacol 1998;353:149-58.
45. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu X-T, et al. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 re ceptors. Neuron 1997;19:837-48.
46. Koeltzow TE, Xu M, Cooper DC, Hu X-T, Tonegawa S, Wolf ME, et al. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 1998;182231-8.
47. 3 dopamine receptor-deficient mouse: evidence for reduced anxiety. Physiol Behav 1998;63: 137-41.
48. Xu MX, Koeltzow TE, Cooper DC, Tonegawa S, White FJ. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse 1999;31:210-15.